AstraZeneca

Total 32 Posts

COVID-19 in India: An unfolding humanitarian crisis.

6 min read
Stories of reaching herd immunity were certainly premature. We may easily have “the next India” just around the corner. How much excess death must we see before global cooperations overcome the “me first” approaches from the wealthier countries?

The week in Covid-19.

8 min read
We look back at last week’s coronavirus situation in the UK, adenovirus-based vaccines link to blood clots, concerning variants landing on our shores, Boris Johnson’s roadmap danger, and more...

What is capillary leak syndrome and is it linked to the AstraZeneca vaccine?

5 min read
European regulators are investigating a possible link between the AstraZeneca vaccine and a second rare blood disorder.

The best hope for fairly distributing COVID-19 vaccines globally is at risk of failing.

6 min read
COVAX, the global vaccine distribution initiative, is well behind its goal of delivering 2 billion doses this year due to under-investment, vaccine nationalism and export restrictions.

Is the adenovirus vaccine technology, used by AstraZeneca and Johnson & Johnson, causing blood clots?

5 min read
If one adenoviral vaccine is linked with blood clots, it doesn’t mean all vaccines in this family will have that same effect. But it is definitely worth health authorities assessing the data.

New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’.

5 min read
COVID-19 variants of concern have changed the game. We need to recognise and act on this to avoid future waves of infections, yet more lockdowns and restrictions, and avoidable illness and death.

Did the UK outsmart the EU over AstraZeneca vaccines?

5 min read
The UK says its contract is better – it simply put tougher penalty clauses in place.
You've successfully subscribed to PMP Magazine
Great! Next, complete checkout for full access to PMP Magazine
Welcome back! You've successfully signed in.
Success! Your account is fully activated, you now have access to all content.
";